Assessment of the rational use of the most commonly prescribed antibiotics at the Department of Health of Ramallah in Palestine Omar Al-Taweel, Costa Shubeita, Fairouz Zayed, Doaa Al-Hamed, Doaa Al-Tarifi, et al. Journal of Infection in Developing Countries, 2024 Introduction: Appropriate antibiotic use requires using the right antibiotic, at the right dose, for the right duration, and at the right time. Drug-resistant diseases cause numerous deaths globally a year, and antibiotic stewardship is a cornerstone in fighting antibiotic resistance. This study focuses on tracking the antibiotic prescribing practices in Palestine and improving future antibiotic prescribing. Methodology: Data from prescriptions of the most commonly prescribed antibiotics was collected from the Health Department of Ramallah and Al-Bireh clinics between January 1 to March 31, 2020. The prescriptions were divided into three categories according to the diagnosis status: unwritten, unspecific, and precise diagnosis. The precise prescriptions were further divided into two categories: appropriate or inappropriate indication. Only appropriate prescriptions were candidates for the assessment of dose and duration appropriateness. Results: The percentages of the three categories of diagnosis precise, unspecific, and unwritten were 23.4%, 20.4%, and 56.2%, respectively. The percentage of appropriate prescriptions was 16.2%. Azithromycin was the most over-utilized antibiotic, followed by co-amoxiclav (amoxicillin/clavulanic acid). Amoxicillin and co-trimoxazole (trimethoprim/sulfamethoxazole) were under-prescribed. All the prescriptions indicated for urinary tract infections (UTIs) were inappropriate. Conclusions: Most prescriptions were not candidates for analysis due to missing diagnosis. Amoxicillin, co-amoxiclav, cefuroxime, azithromycin, and ciprofloxacin were the most commonly prescribed antibiotics and were mostly indicated for pharyngitis. The duration of all sinusitis regimens was inappropriate. More rational antibiotic use in the Department of Health could be achieved by improving documentation, following updated guidelines, choosing cost-effective agents, and keeping track of local resistance patterns and antibiograms.
Alarmingly high prevalence of high-risk drug use among palestinian males: a cross-sectional study Salwa Massad, Hadil Dalloul, Lina Adwan, Khalid Abu Saman, Rawan Kafri, et al. BMC Psychiatry, 2023 Background The unique socioeconomic context in Palestine, characterized by political and economic tensions, creates conditions that facilitate the spread of illicit drug use among Palestinians. This paper presents findings from a 2017 survey of high-risk drug use (HRDU) among males in four regions in Palestine: the West Bank (north, middle, and south) and the Gaza Strip. These findings are essential for developing effective policies to respond to the increasing use of drugs among Palestinians. Methods Eligible participants were males aged 15 years and above who used at least one drug other than non-synthetic hashish or marijuana during the previous week. Participants underwent a face-to-face interview and had their drug use verified by urinalysis. Data were collected using respondent-driven sampling and data were analyzed using the successive sampling estimator. Multivariate regression analysis was conducted to examine factors associated with ever seeking rehabilitation services for illicit drug use in the West Bank and the Gaza Strip. Results A total of 400 males who use drugs were sampled in Gaza, plus 299 in the south, 300 in the north, and 299 in the middle region of the West Bank. It is estimated that there are 26,500 male HRDUs in Palestine comprising 1.8% of the male population aged 15 and above. Findings indicate that polydrug use is a serious issue in Palestine, especially in the West Bank, and that synthetic marijuana is prevalent among teenagers and young adults. Conclusions Palestine must strengthen its national efforts to scale up harm reduction and treatment and care options for people suffering from drug use disorders, especially those involved in polydrug use. Additional measures are needed to prevent substance use among children and youth, support the families of people who use drugs, and ensure the continuity of HRDU services during emergencies.
Clinical outcomes of COVID-19 in hemodialysis patients Lina Adwan, Tala Al-Sadi, Shorouq Shawakha, Ni’meh A. Al-Shami Frontiers in Medicine, 2023 BackgroundThe coronavirus disease 2019 (COVID-19) is known for its effects on the respiratory system. Three years after the pandemic morbid and mortal consequences, growing evidence is showing that the disease also has adverse outcomes and complications on additional organs including the kidneys. This study aims at investigating the effects of COVID-19 on hemodialysis patients receiving services at Palestine Medical Complex (PMC) kidney dialysis department, and to identify mortality related risk factors.MethodsIn April 2022, data was collected using the electronic medical records system for the dialysis department at PMC. The study included all PMC hemodialysis patients that were infected with COVID-19 between January 2020–April 2022. The collected data included patient demographics, clinical features, laboratory tests, dialysis frequency and the disease outcome.ResultsThe results showed that the patients’ outcomes and dialysis frequency were impacted by their blood urea nitrogen (BUN), serum creatinine (SCr) and calcium levels. About one third of the study population died after being infected with COVID-19. The frequency of dialysis was also affected by the presence of comorbidities like hypertension, diabetes mellitus (DM) and myocardial infarction (MI).ConclusionThis study found that there was a high mortality rate within the hemodialysis patients infected with COVID-19. Having comorbidities affected the frequency of dialysis following COVID-19 infection. Dialysis patients should be protected from infections such as COVID-19 and their comorbidities should be monitored and kept under control as much as possible.
Composition, Anticholinesterase and Antipedicular Activities of Satureja capitata L. Volatile Oil Nidal Jaradat, Lina Adwan, Abdel Naser Zaid, Shadi K’aibni, Mohammad Arar Open Life Sciences, 2020 The emergence of resistance for antipedicular agents and the need of potent acetylcholinesterase (AChE) therapeutics for the treatment of a neurodegenerative disorder such as Alzheimer disease has led researchers to the exploration of new therapeutic alternatives such as natural volatile oils. Therefore, the current investigation aimed to identify the components of Satureja capitata L. volatile oil (VO), and examine the VO anticholinesterase, and antipedicular activities. The plant phytoconstituents were identified using Gas chromatography mass spectrometry (GC-MS) method, while the anticholinesterase activity was determined against butyryl- and acetyl-cholinesterase using Ellman’s method. In addition, antipedicular activity was established using the diffusion method. The obtained GC-MS results identified 16 compounds in S. capitata VO with the major constituents being carvacrol, γ-terpinene, and p-cymene. Anticholinesterase analysis showed a marked inhibition potential against acetyl- and butyryl-cholinesterase enzymes with half maximal inhibitory concentration (IC50) values of 28.24±0.97 μg/ml and 92.31±1.22 μg/ml, respectively in comparison with the reference compound galantamine, which has IC50 values against the same enzymes of 5.21±0.07 μg/ml and 10.33±0.37 μg/ml, respectively. In addition, the VO, at a concentration of 20%, was effective against head lice, similar to benzyl benzoate, which resulted in 100% mortality. In addition, the VO completely inhibited the emergence of lice nits after 6 and 14 days. On the basis of the obtained results, S. capitata VO is a promising natural alternative to synthetic antipedicular and anticholinesterase drugs, which can be employed in drug development, and may lead to new candidates against head lice and neurodegenerative diseases.
Screening of Antioxidant and Antimicrobial Activity of Micromeria fruticosa serpyllifolia Volatile Oils: A Comparative Study of Plants Collected from Different Regions of West Bank, Palestine Nihaya Salameh, Naser Shraim, Nidal Jaradat, Motasem El Masri, Lina Adwan, et al. Biomed Research International, 2020 Background. The investigation of volatile oils used in traditional medicine is vital to enhance the quality of healthcare. This study is aimed at screening the antioxidant and antimicrobial properties of Micromeria fruticosa serpyllifolia volatile oils from three different regions in Palestine (north, middle, and south). Methods. Volatile oils of three samples of M. fruticosa serpyllifolia were extracted using the microwave-ultrasonic apparatus. The antioxidant activity of the volatile oils was assessed by inhibition of DPPH free radical. The antimicrobial activity was examined using the broth microdilution method. Assessment of antifungal activity was achieved using the agar dilution method. Results. Screening the biological activity of plant extracts revealed that the sample from Ramallah (middle region) possessed the most potent antioxidant activity with an IC50 value of 0.45 μg/mL. The three samples exhibited broad antimicrobial activity and showed potential antifungal activity. The sample from the southern region showed the highest potency against Shigella sonnei with the lowest reported MIC; the sample from the northern region demonstrated the least potency against clinical isolate of Staphylococcus aureus and “methicillin”-resistant Staphylococcus aureus. Conclusions. The study showed that Micromeria fruticosa serpyllifolia volatile oil samples from different regions in Palestine possess different potential antioxidant and antimicrobial activities that were in line with traditional uses of the plant extracts.
Variability of chemical compositions and antimicrobial and antioxidant activities of ruta chalepensis leaf essential oils from three palestinian regions Nidal Jaradat, Lina Adwan, Shadi K’aibni, Abdel Naser Zaid, Munqez J. Y. Shtaya, et al. Biomed Research International, 2017 Introduction. Interest in essential oils was recently revived with their popularity increasing in medicine, pharmacy, and aromatherapy. This study was performed to identify the chemical compositions of the essential oil of Ruta chalepensis growing wildly in three regions in Palestine and to assess and compare their antimicrobial and antioxidant activities. Methods. Identification of the essential oil was performed by gas chromatography coupled with mass spectrometry (GC-MS). Antimicrobial activity was tested against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Methicillin-Resistant Staphylococcus aureus, and Candida albicans by using minimum inhibitory concentration (MIC) assay, while antioxidant activity was analyzed by using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging method. Results. The essential oils of R. chalepensis from Jerusalem and Hebron regions have almost identical components; the major compounds identified were linalyl acetate and β-linalool; these essential oils exerted potential antioxidant and antibacterial activities. On the other hand, the major components of the plant essential oil from Jenin region were 2-undecanone and 2-nonanone, which exhibited potential antifungal activity. Conclusions. The phytoconstituents and antioxidant and antimicrobial properties of the essential oil of R. chalepensis from different regions in Palestine were established in this study. The obtained results indicate possible applications for R. chalepensis in the treatment of various infectious and noninfectious diseases.
Assessment of the rational use of the most commonly prescribed antibiotics at the Department of Health of Ramallah in Palestine O Al-Taweel, C Shubeita, F Zayed, D Al-Hamed, D Al-Tarifi, M Alnadi, ... The Journal of Infection in Developing Countries 18 (12), 1909-1915 , 2024 2024 Citations: 3
Clinical outcomes of COVID-19 in hemodialysis patients L Adwan, T Al-Sadi, S Shawakha, N Al-Shami Frontiers in Medicine 10 , 2023 2023 Citations: 10
Alarmingly high prevalence of high-risk drug use among palestinian males: a cross-sectional study S Massad, H Dalloul, L Adwan, KA Saman, R Kafri, WA Alia, M Tucktuck, ... BMC psychiatry 23 (1), 700 , 2023 2023 Citations: 6
Israel’s spatial and a-spatial strategy of dispossessing the Jordan Valley’s Palestinian Inhabitants G Falah, S Massad, L Adwan, R Kafri, H Dalloul, A Rhodes GeoJournal 88 (4), 4505-4521 , 2023 2023 Citations: 2
Jordan Valley Under Israeli Ihtilal : A Palestinian Story of Stark Oppression GW Falah, S Massad, L Adwan The Arab World Geographer 25 (1), 1-17 , 2022 2022 Citations: 3
Health informatics in the Arab world C El Jabari, L Adwan Handbook of Healthcare in the Arab World, 1681-1692 , 2021 2021 Citations: 6
Composition, anticholinesterase and antipedicular activities of Satureja capitata L. volatile oil N Jaradat, L Adwan, AN Zaid, S K’aibni, M Arar Open Life Sciences 15 (1), 60-67 , 2020 2020 Citations: 7
Screening of Antioxidant and Antimicrobial Activity of Micromeria fruticosa serpyllifolia Volatile Oils: A Comparative Study of Plants Collected from Different Regions … N Salameh, N Shraim, N Jaradat, M El Masri, L Adwan, S K’aibni, ... BioMed research international 2020 (1), 4851879 , 2020 2020 Citations: 23
Variability of Chemical Compositions and Antimicrobial and Antioxidant Activities of Ruta chalepensis Leaf Essential Oils from Three Palestinian Regions N Jaradat, L Adwan, S K’aibni, AN Zaid, MJY Shtaya, N Shraim, M Assali BioMed research international 2017 (1), 2672689 , 2017 2017 Citations: 77
Chemical composition, anthelmintic, antibacterial and antioxidant effects of Thymus bovei essential oil N Jaradat, L Adwan, S K’aibni, N Shraim, AN Zaid BMC Complementary and Alternative Medicine 16, 1-7 , 2016 2016 Citations: 72
Reduction of Amyloid-β Deposition and Attenuation of Memory Deficits by Tolfenamic Acid GM Subaiea, AH Ahmed, LI Adwan, NH Zawia Journal of Alzheimer's Disease 43 (2), 425-433 , 2015 2015 Citations: 25
Tolfenamic Acid Reduces Tau and CDK5 Levels: Implications for Dementia and Tauopathies. L Adwan, GM Subaiea, R Basha, NH Zawia Journal of neurochemistry 133 (2), 266-272 , 2014 2014 Citations: 46
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers L Adwan, GM Subaiea, NH Zawia Neuropharmacology 79, 596-602 , 2014 2014 Citations: 47
Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice GM Subaiea, LI Adwan, AH Ahmed, KE Stevens, NH Zawia Neurobiology of aging 34 (10), 2421-2430 , 2013 2013 Citations: 60
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease L Adwan, NH Zawia Pharmacology & therapeutics 139 (1), 41-50 , 2013 2013 Citations: 163
Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation UT Sankpal, CM Lee, SF Connelly, O Kayaleh, D Eslin, R Sutphin, ... Cellular Physiology and Biochemistry 32 (3), 675-686 , 2013 2013 Citations: 33
Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology LI Adwan 2013
A novel approach for lowering multiple targets in Alzheimer's disease L Adwan, N Zawia Alzheimer's & Dementia 8 (4), P716 , 2012 2012
Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway LI Adwan, R Basha, M Abdelrahim, GM Subaiea Bentham Science , 2011 2011 Citations: 42
Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice R Dosunmu, J Wu, L Adwan, B Maloney, MR Basha, CA McPherson, ... Journal of Alzheimer's Disease 18 (1), 211-230 , 2009 2009 Citations: 34
MOST CITED SCHOLAR PUBLICATIONS
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease L Adwan, NH Zawia Pharmacology & therapeutics 139 (1), 41-50 , 2013 2013 Citations: 163
Variability of Chemical Compositions and Antimicrobial and Antioxidant Activities of Ruta chalepensis Leaf Essential Oils from Three Palestinian Regions N Jaradat, L Adwan, S K’aibni, AN Zaid, MJY Shtaya, N Shraim, M Assali BioMed research international 2017 (1), 2672689 , 2017 2017 Citations: 77
Chemical composition, anthelmintic, antibacterial and antioxidant effects of Thymus bovei essential oil N Jaradat, L Adwan, S K’aibni, N Shraim, AN Zaid BMC Complementary and Alternative Medicine 16, 1-7 , 2016 2016 Citations: 72
Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice GM Subaiea, LI Adwan, AH Ahmed, KE Stevens, NH Zawia Neurobiology of aging 34 (10), 2421-2430 , 2013 2013 Citations: 60
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers L Adwan, GM Subaiea, NH Zawia Neuropharmacology 79, 596-602 , 2014 2014 Citations: 47
Tolfenamic Acid Reduces Tau and CDK5 Levels: Implications for Dementia and Tauopathies. L Adwan, GM Subaiea, R Basha, NH Zawia Journal of neurochemistry 133 (2), 266-272 , 2014 2014 Citations: 46
Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway LI Adwan, R Basha, M Abdelrahim, GM Subaiea Bentham Science , 2011 2011 Citations: 42
Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice R Dosunmu, J Wu, L Adwan, B Maloney, MR Basha, CA McPherson, ... Journal of Alzheimer's Disease 18 (1), 211-230 , 2009 2009 Citations: 34
Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation UT Sankpal, CM Lee, SF Connelly, O Kayaleh, D Eslin, R Sutphin, ... Cellular Physiology and Biochemistry 32 (3), 675-686 , 2013 2013 Citations: 33
Reduction of Amyloid-β Deposition and Attenuation of Memory Deficits by Tolfenamic Acid GM Subaiea, AH Ahmed, LI Adwan, NH Zawia Journal of Alzheimer's Disease 43 (2), 425-433 , 2015 2015 Citations: 25
Screening of Antioxidant and Antimicrobial Activity of Micromeria fruticosa serpyllifolia Volatile Oils: A Comparative Study of Plants Collected from Different Regions … N Salameh, N Shraim, N Jaradat, M El Masri, L Adwan, S K’aibni, ... BioMed research international 2020 (1), 4851879 , 2020 2020 Citations: 23
Clinical outcomes of COVID-19 in hemodialysis patients L Adwan, T Al-Sadi, S Shawakha, N Al-Shami Frontiers in Medicine 10 , 2023 2023 Citations: 10
Composition, anticholinesterase and antipedicular activities of Satureja capitata L. volatile oil N Jaradat, L Adwan, AN Zaid, S K’aibni, M Arar Open Life Sciences 15 (1), 60-67 , 2020 2020 Citations: 7
Alarmingly high prevalence of high-risk drug use among palestinian males: a cross-sectional study S Massad, H Dalloul, L Adwan, KA Saman, R Kafri, WA Alia, M Tucktuck, ... BMC psychiatry 23 (1), 700 , 2023 2023 Citations: 6
Health informatics in the Arab world C El Jabari, L Adwan Handbook of Healthcare in the Arab World, 1681-1692 , 2021 2021 Citations: 6
Assessment of the rational use of the most commonly prescribed antibiotics at the Department of Health of Ramallah in Palestine O Al-Taweel, C Shubeita, F Zayed, D Al-Hamed, D Al-Tarifi, M Alnadi, ... The Journal of Infection in Developing Countries 18 (12), 1909-1915 , 2024 2024 Citations: 3
Jordan Valley Under Israeli Ihtilal : A Palestinian Story of Stark Oppression GW Falah, S Massad, L Adwan The Arab World Geographer 25 (1), 1-17 , 2022 2022 Citations: 3
Israel’s spatial and a-spatial strategy of dispossessing the Jordan Valley’s Palestinian Inhabitants G Falah, S Massad, L Adwan, R Kafri, H Dalloul, A Rhodes GeoJournal 88 (4), 4505-4521 , 2023 2023 Citations: 2
Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology LI Adwan 2013
A novel approach for lowering multiple targets in Alzheimer's disease L Adwan, N Zawia Alzheimer's & Dementia 8 (4), P716 , 2012 2012